Study Identifies Benefits and Risks of GLP-1 Drugs Across 175 Health Outcomes
A recent study published in Nature Medicine may provide valuable insights into the previously unreported benefits and risks of glucagon-like peptide-1 (GLP-1) receptor agonist use on a set of 175 health outcomes.
A recent study published in Nature Medicine may provide valuable insights into the previously unreported benefits and risks of glucagon-like peptide-1 (GLP-1) receptor agonist use on a set of 175 health outcomes.
